HCA Healthcare, Inc. $HCA Shares Sold by CI Investments Inc.

CI Investments Inc. trimmed its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 11.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,594 shares of the company’s stock after selling 1,992 shares during the quarter. CI Investments Inc.’s holdings in HCA Healthcare were worth $6,646,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Norges Bank acquired a new position in shares of HCA Healthcare during the 2nd quarter valued at $1,152,408,000. Viking Global Investors LP grew its holdings in HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after acquiring an additional 690,773 shares during the period. Nordea Investment Management AB lifted its holdings in HCA Healthcare by 5.2% in the 3rd quarter. Nordea Investment Management AB now owns 975,741 shares of the company’s stock valued at $415,656,000 after acquiring an additional 47,960 shares during the last quarter. Pacer Advisors Inc. raised its holdings in shares of HCA Healthcare by 6,115.3% in the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock worth $388,309,000 after purchasing an additional 896,437 shares in the last quarter. Finally, LSV Asset Management boosted its holdings in HCA Healthcare by 0.4% during the second quarter. LSV Asset Management now owns 868,849 shares of the company’s stock worth $332,856,000 after buying an additional 3,396 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Up 0.5%

Shares of NYSE:HCA opened at $544.72 on Thursday. HCA Healthcare, Inc. has a 1 year low of $310.18 and a 1 year high of $552.90. The business has a fifty day simple moving average of $498.00 and a 200 day simple moving average of $463.50. The firm has a market cap of $121.81 billion, a price-to-earnings ratio of 19.19, a P/E/G ratio of 1.66 and a beta of 1.34.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The company had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same period last year, the business earned $6.22 EPS. The business’s quarterly revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.15%.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on HCA. Barclays raised their price objective on HCA Healthcare from $494.00 to $551.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 28th. Leerink Partners lifted their price target on HCA Healthcare from $507.00 to $573.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 28th. TD Cowen reiterated a “buy” rating on shares of HCA Healthcare in a report on Wednesday, January 28th. Wells Fargo & Company upped their price target on shares of HCA Healthcare from $452.00 to $481.00 and gave the company an “equal weight” rating in a research report on Friday, January 30th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research note on Wednesday. Sixteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $534.50.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,500 shares of the firm’s stock in a transaction dated Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the transaction, the executive vice president directly owned 30,003 shares in the company, valued at $14,944,194.27. This trade represents a 4.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the transaction, the senior vice president directly owned 44,379 shares in the company, valued at approximately $22,411,395. This represents a 8.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 15,214 shares of company stock valued at $7,797,595. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.